The latest price target for Rockwell Medical (NASDAQ:RMTI) was reported by HC Wainwright & Co. on September 4, 2024. The analyst firm set a price target for $9.00 expecting RMTI to rise to within 12 months (a possible 209.28% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Rockwell Medical (NASDAQ:RMTI) was provided by HC Wainwright & Co., and Rockwell Medical reiterated their buy rating.

There is no last upgrade for Rockwell Medical

There is no last downgrade for Rockwell Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rockwell Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rockwell Medical was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a reiterated with a price target of $9.00 to $9.00. The current price Rockwell Medical (RMTI) is trading at is $2.91, which is out of the analyst’s predicted range.